A Study of Cisapride in Premature Infants With Feeding Problems

• Status: Terminated
• Trial end date: 2003-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effectiveness of Cisapride in improving feeding problems in premature newborn infants.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
• Treatments: Cisapride

Criteria

Inclusion Criteria:

• Must be hospitalized and on continuous cardiac monitoring for the duration of the study

• Patient has demonstrated feeding intolerance as defined by the protocol

• Patient's parent or legal guardian must sign the informed consent form

Exclusion Criteria:

• Currently active significant cardiovascular disease, as determined by the neonatologist/physician, including congenital heart disease and heart block (patent ductus arteriosus without cardiac compromise at the time of randomization is acceptable)